Beijing Cytoniche Biotechnology Co., Ltd.was established in 2018, led by Professor Dua Nan from the School of Medicine at Tsinghua University, with co-construction by Tsinghua University. Its core technology is derived from the technology transfer of Tsinghua University and has received multiple national funding and support for its applications.

As an expert in high-quality three-dimensional cell manufacturing, Cytoniche provides one-stop customized solutions for cell-scale amplification based on 3D microcarriers. We have created an original 3D cell intelligent manufacturing platform, achieving large-scale, automated, intelligent, and closed-cell drug and derivative production preparation. This helps global customers establish the most advanced cell drug production lines. After pioneering the preparation pipeline for billion-level stem cells, we are accelerating towards trillion-level production, dedicated to empowering the cell and gene therapy industry with 3D cell-scale intelligent manufacturing technology to benefit more patients.

Currently, Cytoniche 's products and services have been widely applied in upstream process development for gene and cell therapy, extracellular vesicles, vaccines, protein products, and more. We also have extensive applications in the fields of regenerative medicine, organoids, and food technology (cell-cultured meat, etc.).

Cytoniche has a research and development platform of over 5,000 square meters, including a CDMO service platform of more than 1,000 square meters focused on 3D cell intelligent manufacturing and microtissue regenerative medical products. We also have a 4,000-square-meter GMP production platform and a newly built 1,200L microcarrier production line. In addition, we have an international cooperation and technology application center of over 2,000 square meters in Shanghai, continuously integrating technological innovation into the global biotechnology industry's new formats.